Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 64 EP applications Regina Poppe has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 17, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12705884

BRIDGED PIPERIDINE DERIVATIVES

IPC classification:
A61K 31/4196, C07D 519/00, C07D 471/04, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12709643

HETEROCYCLIC AMINE DERIVATIVES

IPC classification:
C07D 417/12, C07D 413/14, C07D 413/12, C07D 403/12, C07D 401/12, C07D 265/30, C07D 211/26, C07D 207/09
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12714324

5-(PHENYL/PYRIDINYL-ETHINYL)-2-PYRIDINE/ 2-PYRIMIDINE-CARBORXAMIDES AS MGLUR5 MODULATORS

IPC classification:
A61K 31/506, A61K 31/445, A61K 31/4427, C07D 413/06, C07D 407/12, C07D 403/06, C07D 401/06, C07D 239/28, C07D 213/57, C07D 213/56, A61P 25/28, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12718153

ETHYNYL DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS OF THE MGLUR5

IPC classification:
A61K 31/55, A61K 31/506, A61K 31/501, A61K 31/4406, A61K 31/44, C07D 403/04, C07D 401/14, C07D 401/04, A61P 25/30, A61P 25/28, A61P 25/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12716007

PYRAZOLIDIN-3-ONE DERIVATIVES

IPC classification:
A61K 31/45, C07D 487/04, C07D 403/04, C07D 401/04, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12727633

SUBSTITUTED BENZAMIDE DERIVATIVES

IPC classification:
A61K 31/4245, C07D 413/14, C07D 413/12, C07D 401/12, C07D 265/30, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12727632

PYRAZOLE DERIVATIVES

IPC classification:
A61K 31/4245, C07D 413/14, C07D 413/12, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12772100

ETHYNYL DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS

IPC classification:
A61K 31/505, A61K 31/50, A61K 31/44, C07D 239/42, C07D 237/22
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12767005

ETHYNYL DERIVATIVES AS MGLUR5 ALLOSTERIC MODULATORS

IPC classification:
A61K 31/506, A61K 31/4439, C07D 413/04, C07D 403/04, C07D 401/04, A61P 25/28, A61P 25/18, A61P 25/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13700984

HETEROCYCLIC DERIVATIVES AS TRACE AMINE ASSOCIATED RECEPTORS (TAARS)

IPC classification:
A61K 31/5377, C07D 471/04, C07D 413/14, C07D 413/10, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14174022

Pharmaceutical compositions of metabotropic glutamate 5 receptor (MGLU5) antagonists

IPC classification:
A61K 31/4439, A61K 9/50, A61K 9/20, A61K 9/16
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13735315

ARYLETHYNYL DERIVATIVES

IPC classification:
A61K 31/403, C07D 209/52, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13739453

BENZISOXAZOLE MODULATORS OF NEUROGENESIS

IPC classification:
A61K 31/423, C07D 413/14, C07D 413/04, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13745648

PIPERAZINO[1,2-A]INDOL-1-ONES AND [1,4]DIAZEPINO[1,2-A]INDOL-1-ONE

IPC classification:
C07D 487/04, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13747827

ARYLETHYNYL PYRIMIDINES

IPC classification:
A61K 31/506, C07D 403/04, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13745668

IMIDAZO[2,1]THIAZOL-3-ONE DERIVATIVES USEFUL AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE

IPC classification:
A61K 31/429, C07D 513/04, A61P 25/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13759754

PYRAZOLE CARBOXAMIDE DERIVATIVES AS TAAR MODULATORS FOR USE IN THE TREATMENT OF SEVERAL DISORDERS, SUCH AS DEPRESSION, DIABETES AND PARKINSON'S DISEASE

IPC classification:
A61K 31/5377, A61K 31/454, A61K 31/4155, C07D 417/14, C07D 413/14, C07D 413/12, C07D 403/12, C07D 401/12, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13762475

TRIAZOLE CARBOXAMIDE DERIVATIVES

IPC classification:
A61K 31/4196, A61K 31/4192, C07D 413/12, C07D 403/12, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13759241

2-OXO-2,3-DIHYDRO-INDOLES FOR THE TREATMENT OF CNS DISORDERS

IPC classification:
A61K 31/506, A61K 31/44, A61K 31/437, A61K 31/4178, A61K 31/404, C07D 471/04, C07D 403/12, C07D 401/14, C07D 401/12, C07D 209/34, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13766286

ARYLETHYNYL DERIVATIVES

IPC classification:
A61K 31/444, C07D 413/04, A61P 25/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13766557

BENZIMIDAZOLES AS CNS ACTIVE AGENTS

IPC classification:
A61K 31/4184, C07D 403/04, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13788730

PYRAZINE DERIVATIVES

IPC classification:
C07D 413/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13795705

SUBSTITUTED 1,6-NAPHTHYRIDINES

IPC classification:
A61K 31/4375, A61P 25/30, A61P 25/28, A61P 25/24
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13795268

IMIDAZOPYRIDINE DERIVATIVES

IPC classification:
C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13814079

PEPTIDES AS OXYTOCIN AGONISTS

IPC classification:
C07K 7/16
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13820775

COMT INHIBITORS

IPC classification:
A61K 31/517, C07D 471/04, C07D 417/10, C07D 417/04, C07D 413/04, C07D 409/14, C07D 409/04, C07D 405/04, C07D 403/10, C07D 403/04, C07D 401/12, C07D 401/10, C07D 401/04, C07D 239/88, A61P 25/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14700614

OXYTOCIN RECEPTOR AGONISTS FOR THE TREATMENT OF CNS DISEASES

IPC classification:
A61K 31/506, A61K 31/4439, A61K 31/433, A61K 31/427, A61K 31/415, A61P 25/30, A61P 25/24, A61P 25/22, A61P 25/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14717110

PIPERAZINO[1,2-A]INDOL-1-ONES AND [1,4]DIAZEPINO[1,2-A]INDOL-1-ONE

IPC classification:
A61P 25/00, A61K 31/551, A61K 31/4985, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP14721815

NEUROGENESIS-STIMULATING ISOQUINOLINE DERIVATIVES

IPC classification:
A61K 31/4725, A61K 31/472, A61K 31/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14719326

2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES

IPC classification:
A61P 9/00, A61K 31/437, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP12700009

PYRROLIDINE DERIVATIVES AS NK3 ANTAGONISTS

IPC classification:
C07D 407/06, A61P 25/00, A61K 31/4025, C07D 413/10, C07D 403/06, C07D 401/14, C07D 401/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14724757

2-PHENYLIMIDAZO[1,2-A]PYRIMIDINES AS IMAGING AGENTS

IPC classification:
A61K 31/519, C07D 487/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14729920

INDOLIN-2-ONE OR PYRROLO-PYRIDIN/PYRIMIDIN-2-ONE DERIVATIVES

IPC classification:
A61K 31/4402, A61K 31/4406, A61K 31/4409, A61K 31/44, A61P 25/00, C07D 498/04, C07D 487/04, C07D 471/04, C07D 417/04, C07H 19/044, C07D 413/04, C07D 403/04, C07D 401/04, C07D 413/14, C07D 405/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14739714

ETHYNYL DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/00, A61K 31/506, A61K 31/4439, C07D 403/04, C07D 401/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14744539

1,7-NAPHTHYRIDINE DERIVATIVES

IPC classification:
A61P 25/00, C07D 498/04, A61K 31/4375, C07D 401/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14755820

PYRROLOPYRIDINE OR PYRAZOLOPYRIDINE DERIVATIVES

IPC classification:
A61P 25/28, A61P 25/18, A61P 25/00, A61K 31/437, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14761651

INDOL-CARBOXAMIDE DERIVATIVES

IPC classification:
A61P 25/30, A61P 25/28, A61P 25/24, A61P 25/22, A61P 25/18, A61P 25/00, A61K 31/4439, A61K 31/404, C07D 401/04, C07D 209/24, C07D 209/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP14781474

ETHYNYL DERIVATIVES

IPC classification:
A61P 25/24, A61P 25/22, A61P 25/10, A61P 3/10, A61K 31/517, C07D 513/04, C07D 495/04, C07D 487/04, C07D 473/04, C07D 471/04, C07D 239/91, C07D 405/04, C07D 401/10, C07D 401/04, C07D 405/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14771582

IMIDAZO[1,2-A]PYRIDIN-7-AMINES AS IMAGING TOOLS

IPC classification:
A61P 25/28, A61K 31/4353, A61K 31/437, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP14772317

INDOL AND INDAZOL DERIVATIVES

IPC classification:
A61P 25/28, A61K 31/416, A61K 31/404, C07D 471/04, C07D 417/14, C07D 413/14, C07D 405/14, C07D 405/12, C07D 403/10, C07D 209/42
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14781169

DIAZACARBAZOLE DERIVATIVES AS TAU-PET-LIGANDS

IPC classification:
A61P 25/28, A61K 31/44, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP14796743

PYRIDO[4,3-B]PYRAZINE-2-CARBOXAMIDES AS NEUROGENIC AGENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

IPC classification:
A61P 25/22, A61P 25/24, A61P 25/18, A61K 31/4985, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP11776154

DIHYDROOXAZOL-2-AMINE DERIVATIVES

IPC classification:
A61P 25/00, A61K 31/506, C07D 413/14, C07D 413/12, C07D 263/16
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14806235

PHARMACEUTICAL COMPOSITION

IPC classification:
A61K 31/496, A61K 9/20
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15700850

ETHYNYL-IMIDAZOLIN-2,4-DIONE DERIVATIVES AS MGLUR4 MODULATORS

IPC classification:
A61P 25/18, A61K 31/506, C07D 401/04, C07D 233/64
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15700244

N-PHENYL-LACTAM DERIVATIVES CAPABLE OF STIMULATING NEUROGENESIS AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS

IPC classification:
A61P 25/00, C07D 413/10, C07D 403/10, A61K 31/513, A61K 31/4439, A61K 31/422, A61K 31/4178, A61K 31/4155, C07D 401/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15706788

ETHYNYL DERIVATIVES

IPC classification:
A61P 25/22, A61P 25/16, A61K 31/505, A61K 31/519, A61K 31/527, A61K 31/506, C07D 498/04, C07D 491/107, C07D 487/04, C07D 471/04, C07D 239/22, C07D 403/04, C07D 401/10, C07D 401/04, C07D 401/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15721608

MORPHOLIN-PYRIDINE DERIVATIVES

IPC classification:
A61P 25/00, A61K 31/4245, C07D 413/12
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP15717916

GLYT1 INHIBITORS FOR USE IN THE TREATMENT OF HEMATOLOGICAL DISORDERS

IPC classification:
A61P 7/00, A61K 31/496, A61K 31/495, A61K 31/437, A61K 31/4035
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP15725253

DEUTERATED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IMAGING AGENTS

IPC classification:
A61K 49/10, A61P 43/00, A61P 25/28, A61K 31/519, A61K 51/04, C07D 487/04, C07B 59/00, C07D 401/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15723917

INDOLIN-2-ONE AND 1,3-DIHYDRO-PYRROLO[3,2-c]PYRIDIN-2-ONE DERIVATIVES

IPC classification:
A61P 25/36, A61P 25/24, A61P 25/34, A61P 25/32, C07D 471/04, C07D 417/14, C07D 411/12, C07D 403/14, C07D 403/04, A61K 31/506, A61K 31/444, A61K 31/4439, A61K 31/4178, C07D 413/14, C07D 401/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15724624

5-OXA-2-AZABICYCLO[2.2.2]OCTAN-4-YL AND 5-OXA-2-AZABICYCLO[2.2.1]HEPTAN-4-YL DERIVATIVES AS TAAR1 MODULATORS

IPC classification:
A61P 25/00, A61K 31/5386, C07D 491/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15725359

PEPTIDES AS OXYTOCIN AGONISTS

IPC classification:
C07K 7/16, A61K 38/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15725069

PEPTIDES AS OXYTOCIN AGONISTS

IPC classification:
A61K 38/08, C07K 7/16
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15730199

INDOLIN-2-ONE OR PYRROLO-PYRIDIN-2-ONE DERIVATIVES

IPC classification:
A61P 25/00, A61K 31/505, A61K 31/44, A61K 31/4164, A61K 31/415, A61K 31/4245, A61K 31/42, A61K 31/404, C07D 471/04, C07D 417/14, C07D 409/14, C07D 403/14, C07D 413/14, C07D 401/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP15742309

2-OXA-5-AZABICYCLO[2.2.1]HEPTAN-3-YL DERIVATIVES

IPC classification:
A61P 25/28, A61K 31/407, A61K 31/35, C07D 491/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15751039

SUBSTITUTED AZETIDINE DERIVATIVES AS TAAR LIGANDS

IPC classification:
A61P 25/00, A61K 31/505, A61K 31/4427, A61K 31/4155, C07D 403/12, C07D 401/12, C07D 205/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15751037

SUBSTITUTED PYRAZINO[2,1-A]ISOQUINOLINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS

IPC classification:
A61P 25/00, A61P 3/00, A61K 31/436, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP17151744

SUBSTITUTED BENZAMIDE DERIVATIVES

IPC classification:
A61P 25/00, A61P 9/00, A61P 3/00, A61K 31/5355, A61K 31/4523, A61K 31/4025, C07D 417/14, C07D 417/12, C07D 413/14, C07D 413/12, C07D 401/12, C07D 401/04, C07D 265/30, C07D 241/04, C07D 211/26, C07D 207/12, C07D 207/10, C07D 207/09
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16709917

3-(4-ETHYNYLPHENYL)HEXAHYDROPYRIMIDIN-2,4-DIONE DERIVATIVES AS MODULATORS OF MGLUR4

IPC classification:
A61P 35/00, A61P 25/00, A61P 3/10, A61K 31/513, C07D 471/04, C07D 417/04, C07D 413/04, C07D 403/04, C07D 405/14
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15742253

6-AMINO-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL OR 3-AMINOCHROMAN-7-YL DERIVATIVES AS TAAR MODULATORS

IPC classification:
C07D 405/04, C07C 211/60, C07D 213/82, C07C 255/60, C07C 255/58, C07D 213/74, C07D 213/73, A61P 25/00, A61K 31/167, A61K 31/505, A61K 31/415, A61K 31/435, C07C 233/80, C07D 261/20, C07D 413/12, C07D 239/28, C07D 231/14, C07D 311/04, C07D 213/81
Applicant:
F. Hoffmann-La Roche AG
Agent:
Regina Poppe, F. Hoffmann-La Roche AG
Status:
Grant of patent is intended
EP16727661

ETHYNYL DERIVATIVES

IPC classification:
A61P 1/00, A61P 25/00, A61K 31/4439, C07D 401/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16739442

ETHYNYL DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS

IPC classification:
A61P 25/00, A61K 31/527, C07D 491/20, C07D 491/107, C07D 487/10, C07D 471/10, C07D 401/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16736493

2-PHENYL-6-IMIDAZOLYL-PYRIDINE-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS EAAT3 INHIBITORS

IPC classification:
A61P 25/18, A61K 31/4439, C07D 409/14, C07D 401/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, F. Hoffmann-La Roche AG
Status:
Request for examination was made

Please Sign in to use this feature